The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

• Status: Recruiting
• Trial end date: 2025-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Southern California
• Treatments: Zolpidem

Criteria

Inclusion Criteria:

• degenerative lumbar disease

• age of 18-75

• undergoing open primary one- to three-level lumbar fusion

Exclusion Criteria:

• currently use a sleep aid nightly

• diagnosed with insomnia or sleep apnea

• history of delirium with opiates or zolpidem

• allergic to opiates or zolpidem

• had previous lumbar spine surgery

• undergoing minimally invasive lumbar fusion,

• undergoing lumbar fusion for fracture, infection, tumor, or an inflammatory spondyloarthropathy